Uptake of HPV vaccination among boys after the introduction of gender-neutral HPV vaccination in Germany before and during the COVID-19 pandemic.

Authors:
Wähner C; Hübner J; Meisel D; Schelling J; Zingel R and 3 more

Journal:
Infection

Publication Year: 2023

DOI:
10.1007/s15010-023-01978-0

PMCID:
PMC9913033

PMID:
36763286

Journal Information

Full Title: Infection

Abbreviation: Infection

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestCW, SM, MR are full-time employees of MSD Sharp and Dohme GmbH. RW was a full-time employee at the time of the study. RZ is a full-time employee of IQVIA and has acted as a subcontractor of MSD Sharp and Dohme GmbH in conducting this study. JS has received expense allowances from the following companies: MSD Sharp and Dohme GmbH, Sanofi-Pasteur, Pfizer, Seqirus, GSK. JH has received an expense allowance from MSD Sharp and Dohme GmbH. DM has received expense allowances from MSD Sharp & Dohme GmbH and Gedeon-Richter. Ethical approvalNot applicable. Conflict of interest CW, SM, MR are full-time employees of MSD Sharp and Dohme GmbH. RW was a full-time employee at the time of the study. RZ is a full-time employee of IQVIA and has acted as a subcontractor of MSD Sharp and Dohme GmbH in conducting this study. JS has received expense allowances from the following companies: MSD Sharp and Dohme GmbH, Sanofi-Pasteur, Pfizer, Seqirus, GSK. JH has received an expense allowance from MSD Sharp and Dohme GmbH. DM has received expense allowances from MSD Sharp & Dohme GmbH and Gedeon-Richter."

Evidence found in paper:

"Funding This study was funded by MSD Sharp and Dohme GmbH."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025